1-4 of 4
Michael B Atkins, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematological Malignancies — CPIT-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Robert Korngold, PhD, Rena Feinman, PhD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD PhD, Pashna N. Munshi, MD, David S Siegel, MD PhD, Tatyana A. Feldman, MD, Noa Biran, MD, Lori A. Leslie, MD, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 256.
https://doi.org/10.1182/blood-2018-99-113586
Published: 2018
Journal Articles

Evaluation of Treg and Memory T Cell Profiles, Post-ASCT with Early Combination Nivolumab/Ipilimumab Therapy, in Patients with Multiple Myeloma (MM) and Diffuse Large B Cell Lymphoma (DLBCL)

Dante B. Descalzi-Montoya, PhD, Zheng Yang, MS, Kira Goldgirsh, MS, Rena Feinman, PhD, Stacey L. Fanning, PhD, David H. Vesole, MD PhD, Pashna N. Munshi, MD, Michael B Atkins, MD, Scott D. Rowley, MD, Noa Biran, MD, David S Siegel, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Michele L. Donato, MD, Alan P Skarbnik, MD, Andrew L. Pecora, MD, Robert Korngold, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3421.
https://doi.org/10.1182/blood-2018-99-120240
Published: 2018
Journal Articles

Influence of the Gut Microbiome on Clinical Outcomes in the CPIT-001 Trial, a Phase Ib-IIA Study of Combined Checkpoint Inhibition with Nivolumab and Ipilimumab after Autologous Hematopoietic Stem Cell Transplantation in Patients at High-Risk for Post-Transplant Recurrence

Rena Feinman, PhD, Tracy Andrews, MSc, Iriana Colorado, MSc, Joshua Zenreich, Suzanne Kosky, BS, Themba Nyirenda, PhD, Noa Biran, MD, David S Siegel, MD PhD, David H. Vesole, MD PhD, Michele L. Donato, MD, Scott D. Rowley, MD, Pashna N. Munshi, MD, Michael B Atkins, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Andre Goy, MD, Robert Korngold, PhD, Alan P Skarbnik, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3443.
https://doi.org/10.1182/blood-2018-99-117669
Published: 2018
Journal Articles

Preliminary Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (I) and Nivolumab (N) As Consolidation Following Autologous Stem Cell Transplantation (ASCT) for High-Risk Hematologic Malignancies - Cpit-001 Trial

Alan P Skarbnik, MD, Michele L. Donato, MD, Scott D. Rowley, MD, Andre Goy, MD, David H. Vesole, MD, Pashna N. Munshi, MD, David Siegel, MD PhD, Noa Biran, MD, Joshua R Richter, MD, Tatyana A Feldman, MD, Lori A. Leslie, MD, Mary E Dilorenzo, APN, Phyllis McKiernan, APN, MSN, Melissa Baker, MSN, ANP, Michele Boonstra, APN, Michele Simone, APN, Ann McNeill, ANP, Ernest Richards, PhD, Joshua Zenreich, Mariefel Vendivil, RN, Andrea Ortega, RN, Jacquelyn Callahan, RN, Michael B Atkins, MD, Andrew L. Pecora, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 340.
https://doi.org/10.1182/blood.V130.Suppl_1.340.340
Published: 2017